Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
EN

ENOV

Market Closed

Enovis Corporation

NYSEHealthcareMedical - Devices
US
7.80K employees
CEO: Damien McDonald
Founded: 2008
$18.56
+$0.00(+NaN%)
Market Cap
1.07B
Beta
1.43
52W Range
N/A
Dividend Yield
0.00%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Based on PERT weighted analysis (confidence: high), the fair value is $29.90, implying 61.1% upside from current levels. The stock appears significantly undervalued. Financial health scores indicate moderate fundamentals (2.0/5). Monte Carlo analysis shows low downside risk (0% of scenarios below current price). Overall, this suggests a compelling buying opportunity at current prices.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore ENOV

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

ENOV in the Healthcare

Small Cap
Healthcare

Browse sector stocks →

Medical - Devices

Browse industry stocks →